80 related articles for article (PubMed ID: 23940730)
1. Comparison of steroid-free immunosuppression and standard immunosuppression for liver transplant patients with hepatocellular carcinoma.
Xing T; Huang L; Yu Z; Zhong L; Wang S; Peng Z
PLoS One; 2013; 8(8):e71251. PubMed ID: 23940730
[TBL] [Abstract][Full Text] [Related]
2. Early steroids after pediatric liver transplantation protect against T-cell-mediated rejection: Results from the ChilSFree study.
Goldschmidt I; Chichelnitskiy E; Götz J; Rübsamen N; Karch A; Jäger V; Kelly D; Lloyd C; Debray D; Girard M; d'Antiga L; di Giorgio A; Hierro L; Pawlowska J; Klaudel-Dreszler M; McLin V; Korff S; Falk C; Baumann U
Liver Transpl; 2024 Mar; 30(3):288-301. PubMed ID: 37678230
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of steroid-free tacrolimus-basiliximab immunosuppression in pediatric liver transplantation and predictors for steroid requirement.
Trezeguet Renatti G; Riva N; Minetto J; Reijenstein H; Gole M; Meza V; Bosaleh A; Licciardone N; Aredes D; Lauferman L; Cervio G; Dip M; Schaiquevich P; Halac E; Imventarza O
Liver Transpl; 2024 Jan; 30(1):61-71. PubMed ID: 37439661
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppression in liver transplant oncology: position paper of the Italian Board of Experts in Liver Transplantation (I-BELT).
Cillo U; Carraro A; Avolio AW; Cescon M; Di Benedetto F; Giannelli V; Magistri P; Nicolini D; Vivarelli M; Lanari J;
Updates Surg; 2024 Jun; 76(3):725-741. PubMed ID: 38713396
[TBL] [Abstract][Full Text] [Related]
5. Freedom isn't free: Assessing the risks and benefits of steroid-free immunosuppression regimens in pediatric liver transplantation in a real-world setting.
Peters AL; Perito ER
Liver Transpl; 2024 Mar; 30(3):242-243. PubMed ID: 38009913
[No Abstract] [Full Text] [Related]
6. Brief overview of immunosuppression and its side effects after liver transplantation.
Rabiee A; Girone G; Davis JPE
Clin Liver Dis (Hoboken); 2023 Jun; 21(6):160-164. PubMed ID: 37937047
[TBL] [Abstract][Full Text] [Related]
7. The Science and Art of Immunosuppression in Liver Transplantation.
Saigal S; Anand AC
J Clin Exp Hepatol; 2023; 13(5):728-729. PubMed ID: 37693262
[No Abstract] [Full Text] [Related]
8. Efficacy of immunosuppression monotherapy after liver transplantation: a meta-analysis.
Lan X; Liu MG; Chen HX; Liu HM; Zeng W; Wei D; Chen P
World J Gastroenterol; 2014 Sep; 20(34):12330-40. PubMed ID: 25232269
[TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of Budesonide for Liver Transplant Immune Suppression: Results of a Pilot Phase 2a Trial.
Bari K; Shah SA; Kaiser TE; Cohen RM; Anwar N; Kleesattel D; Sherman KE
Liver Transpl; 2020 Nov; 26(11):1430-1440. PubMed ID: 32602616
[TBL] [Abstract][Full Text] [Related]
10. Retraction: Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma.
PLOS ONE Editors
PLoS One; 2019; 14(9):e0222257. PubMed ID: 31483831
[No Abstract] [Full Text] [Related]
11. Hepatocellular cancer and recurrence after liver transplantation: what about the impact of immunosuppression?
Lerut J; Iesari S; Foguenne M; Lai Q
Transl Gastroenterol Hepatol; 2017; 2():80. PubMed ID: 29167827
[TBL] [Abstract][Full Text] [Related]
12. Optimization of immunosuppressive medication upon liver transplantation against HCC recurrence.
Khorsandi SE; Heaton N
Transl Gastroenterol Hepatol; 2016; 1():25. PubMed ID: 28138592
[TBL] [Abstract][Full Text] [Related]
13. Towards Steroid-Free Immunosuppression after Liver Transplantation.
Zaydfudim VM; Pelletier SJ
Gut Liver; 2016 Jul; 10(4):495-6. PubMed ID: 27377738
[No Abstract] [Full Text] [Related]
14. Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome.
Kornberg A
ISRN Hepatol; 2014; 2014():706945. PubMed ID: 27335840
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in patients with recurrent hepatocellular carcinoma treated with salvage liver transplantation: a single-center study.
Wang P; Li H; Shi B; Que W; Wang C; Fan J; Peng Z; Zhong L
Oncotarget; 2016 Jun; 7(23):35071-83. PubMed ID: 27145461
[TBL] [Abstract][Full Text] [Related]
16. Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival.
Fahrner R; Dondorf F; Ardelt M; Dittmar Y; Settmacher U; Rauchfuß F
World J Gastroenterol; 2015 Nov; 21(42):12071-82. PubMed ID: 26576092
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive comparison of three different immunosuppressive regimens for liver transplant patients with hepatocellular carcinoma: steroid-free immunosuppression, induction immunosuppression and standard immunosuppression.
Liu YY; Li CP; Huai MS; Fu XM; Cui Z; Fan LL; Zhang S; Liu Y; Ma J; Li G; Shen ZY
PLoS One; 2015; 10(3):e0120939. PubMed ID: 25816221
[TBL] [Abstract][Full Text] [Related]
18. Current strategies for immunosuppression following liver transplantation.
Gotthardt DN; Bruns H; Weiss KH; Schemmer P
Langenbecks Arch Surg; 2014 Dec; 399(8):981-8. PubMed ID: 24748543
[TBL] [Abstract][Full Text] [Related]
19. Liver transplantation for hepatocellular carcinoma: role of inflammatory and immunological state on recurrence and prognosis.
Cescon M; Bertuzzo VR; Ercolani G; Ravaioli M; Odaldi F; Pinna AD
World J Gastroenterol; 2013 Dec; 19(48):9174-82. PubMed ID: 24409045
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
